Paper19861964
Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study.
Board RE and 11 others. Br J Cancer, 2009. Cited by 78 papers, by iCite.
Cite this record
ConductScience Library. Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study. Papers, record 19861964. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19861964
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Benzimidazoles | Major topic |
| Melanoma | Major topic |
| Mutation | Major topic |
| Proto-Oncogene Proteins B-raf | Major topic |
| Skin Neoplasms | Major topic |
| Antineoplastic Agents | |
| Cell Line, Tumor | |
| DNA Mutational Analysis | |
| DNA, Neoplasm | |
| Disease-Free Survival | |
| HT29 Cells | |
| Humans | |
| Prognosis |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Cancer Research UK | United Kingdom | PubMed |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04158544 | Immune Monitoring in Metastatic Melanoma | Background |
Source ClinicalTrials.gov
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17315191 | Detection of mutated BRAFV600E variant in circulating DNA of stage III-IV melanoma patients. | Int J Cancer | 2007 | https://conductscience.org/library/papers/17315191 | PubMed |
| 2 | 16368947 | Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays. | J Natl Cancer Inst | 2005 | https://conductscience.org/library/papers/16368947 | PubMed |
| 3 | 17404088 | Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17404088 | PubMed |
| 4 | 8052857 | Transformation of mammalian cells by constitutively active MAP kinase kinase. | Science | 1994 | https://conductscience.org/library/papers/8052857 | PubMed |
| 5 | 2785681 | Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). | Nucleic Acids Res | 1989 | https://conductscience.org/library/papers/2785681 | PubMed |
| 6 | 10454649 | Optimisation of DNA and RNA extraction from archival formalin-fixed tissue. | Nucleic Acids Res | 1999 | https://conductscience.org/library/papers/10454649 | PubMed |
| 7 | 18670422 | Circulating mutant DNA to assess tumor dynamics. | Nat Med | 2008 | https://conductscience.org/library/papers/18670422 | PubMed |
| 8 | 12460918 | BRAF and RAS mutations in human lung cancer and melanoma. | Cancer Res | 2002 | https://conductscience.org/library/papers/12460918 | PubMed |
| 9 | 16818687 | Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/16818687 | PubMed |
| 10 | 14695152 | NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression. | Clin Cancer Res | 2003 | https://conductscience.org/library/papers/14695152 | PubMed |
| 11 | 15373800 | Loitering with intent: new evidence for the role of BRAF mutations in the proliferation of melanocytic lesions. | J Invest Dermatol | 2004 | https://conductscience.org/library/papers/15373800 | PubMed |
| 12 | 15613230 | Clinical significance of BRAF mutations in metastatic melanoma. | J Transl Med | 2004 | https://conductscience.org/library/papers/15613230 | PubMed |
| 13 | 17848912 | Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA). | Br J Cancer | 2007 | https://conductscience.org/library/papers/17848912 | PubMed |
| 14 | 17332304 | Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitor. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17332304 | PubMed |
| 15 | 12068308 | Mutations of the BRAF gene in human cancer. | Nature | 2002 | https://conductscience.org/library/papers/12068308 | PubMed |
| 16 | 17384209 | Detection of mutant BRAF alleles in the plasma of patients with metastatic melanoma. | J Mol Diagn | 2007 | https://conductscience.org/library/papers/17384209 | PubMed |
| 17 | 10873061 | Detection of mutated KRAS2 sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer. | Clin Cancer Res | 2000 | https://conductscience.org/library/papers/10873061 | PubMed |
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37450124 | The Value of Cell-Free Circulating DNA Profiling in Patients with Skin Diseases. | Methods Mol Biol | 2023 | https://conductscience.org/library/papers/37450124 | PubMed |
| 36620597 | Metabolism heterogeneity in melanoma fuels deactivation of immunotherapy: Predict before protect. | Front Oncol | 2022 | https://conductscience.org/library/papers/36620597 | PubMed |
| 36276290 | Evaluating the Diagnostic Potentials of Circulating Tumor DNA against Melanoma: A Systematic Review and Meta-Analysis. | J Oncol | 2022 | https://conductscience.org/library/papers/36276290 | PubMed |
| 34703985 | BRAF V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance). | Mayo Clin Proc Innov Qual Outcomes | 2021 | https://conductscience.org/library/papers/34703985 | PubMed |
| 34035810 | Prognostic Value of ctDNA Mutation in Melanoma: A Meta-Analysis. | J Oncol | 2021 | https://conductscience.org/library/papers/34035810 | PubMed |
| 33091721 | Adaptive redox homeostasis in cutaneous melanoma. | Redox Biol | 2020 | https://conductscience.org/library/papers/33091721 | PubMed |
| 32695793 | The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape. | Front Mol Biosci | 2020 | https://conductscience.org/library/papers/32695793 | PubMed |
| 30487597 | The ERK and JNK pathways in the regulation of metabolic reprogramming. | Oncogene | 2019 | https://conductscience.org/library/papers/30487597 | PubMed |
| 28484715 | Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications. | Biomed Res Int | 2017 | https://conductscience.org/library/papers/28484715 | PubMed |
| 27895798 | Exploring the impact of EGFR T790M neighboring SNPs on ARMS-based T790M mutation assay. | Oncol Lett | 2016 | https://conductscience.org/library/papers/27895798 | PubMed |
| 27259537 | Somatic mutations in histiocytic sarcoma identified by next generation sequencing. | Virchows Arch | 2016 | https://conductscience.org/library/papers/27259537 | PubMed |
| 27249771 | Tumor Heterogeneity and Therapeutic Resistance. | Am Soc Clin Oncol Educ Book | 2016 | https://conductscience.org/library/papers/27249771 | PubMed |
| 26697469 | cfDNA analysis from blood in melanoma. | Ann Transl Med | 2015 | https://conductscience.org/library/papers/26697469 | PubMed |
| 26631873 | Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid Carcinoma. | J Mol Diagn | 2016 | https://conductscience.org/library/papers/26631873 | PubMed |
| 26562020 | SNPase-ARMS qPCR: Ultrasensitive Mutation-Based Detection of Cell-Free Tumor DNA in Melanoma Patients. | PLoS One | 2015 | https://conductscience.org/library/papers/26562020 | PubMed |
| 26347132 | Prognostic and Predictive Value of RAS Gene Mutations in Colorectal Cancer: Moving Beyond KRAS Exon 2. | Drugs | 2015 | https://conductscience.org/library/papers/26347132 | PubMed |
| 26258049 | Detection of BRAF mutations from solid tumors using Tumorplex™ technology. | MethodsX | 2015 | https://conductscience.org/library/papers/26258049 | PubMed |
| 25122430 | Gefitinib treatment in EGFR mutated caucasian NSCLC: circulating-free tumor DNA as a surrogate for determination of EGFR status. | J Thorac Oncol | 2014 | https://conductscience.org/library/papers/25122430 | PubMed |
| 24759937 | DNA hybridization detection with 100 zM sensitivity using piezoelectric plate sensors with an improved noise-reduction algorithm. | Analyst | 2014 | https://conductscience.org/library/papers/24759937 | PubMed |
| 24446311 | BRAF kinase domain mutations are present in a subset of chronic myelomonocytic leukemia with wild-type RAS. | Am J Hematol | 2014 | https://conductscience.org/library/papers/24446311 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| KRAS | 3845 | PubTator's text mining | https://conductscience.org/library/genes/3845 | NCBI Gene |
| MAP2K1 | 5604 | PubTator's text mining | https://conductscience.org/library/genes/5604 | NCBI Gene |
| MAP2K2 | 5605 | PubTator's text mining | https://conductscience.org/library/genes/5605 | NCBI Gene |
| MAP2K7 | 5609 | PubTator's text mining | https://conductscience.org/library/genes/5609 | NCBI Gene |
| NRAS | 4893 | PubTator's text mining | https://conductscience.org/library/genes/4893 | NCBI Gene |
| ZHX2 | 22882 | PubTator's text mining | https://conductscience.org/library/genes/22882 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19861964
GET https://conductscience.org/api/papers/v1/19861964/cited_by?page=2